Ohio State Navbar

Quick Links

Julie Mangino, MD


Julie Mangino, MD

Professor, Internal Medicine, Division of Infectious Diseases
Medical Director, Clinical Epidemiology
The Ohio State University Wexner Medical Center
Doan Hall
410 W 10th Ave
Columbus, OH 43210
P: 614-366-5405
E: julie.mangino@osumc.edu

EDUCATION:

  • State University of New York (SUNY) College of Oneonta, Oneonta, NY, 1973-1977
  • Barnes Hospital School of Dietetics, St. Louis, MI, 1977-1978
  • State University of New York (SUNY), Downstate Brooklyn, NY, 1985-1989
  • Medical College of Virginia, Richmond, VA Residency in Internal Medicine, 1989-1990
  • University of Alabama at Birmingham (UAB), Birmingham, AL Residency in Internal Medicine, 1990-1992
  • University of Alabama at Birmingham (UAB), Birmingham, AL Fellowship in Infectious Diseases, 1992-1995

PROFESSIONAL MEMBERSHIPS:

  • Infectious Diseases Society of America, 1998-Present
  • Society for Health Care Epidemiology of America, 1996-Present
        Fellow 2004-Present
  • Bacteriology and Mycology Study Group, 1995-2001
  • Mycoses Study Group, 2006-Present
  • Reviewer Infection Control and Hospital Epidemiology, 2000-Present
  • Reviewer Annals of Internal Medicine, 1999-Present
  • Reviewer Infectious Diseases in Clinical Practice, 2005-Present
  • Reviewer American Journal of Infection Control, 2007-Present
  • Reviewer International Journal of Infectious Diseases, 2012-Present
  • Reviewer Journal of Hospital Medicine, 2012-Present

SPECIAL AWARDS/RECOGNITION:

  • Leadership Council for Clinical Value Enhancement Award: Prevention of Intravascular Infections Clinical Practice Guideline, 1999
  • Season OMEN Winner Best Team: Fungal Infections, 2000
  • OMEN Best Program Winner: Managing the Diseases of Bioterrorism, 2001
  • Leadership Council for Clinical Value Enhancement Award: Preoperative Prophylactic Antibiotics to Prevent SSI Clinical Practice Guideline, 2003
  • Best Doctors in America® Elected by Peers, US News and World Report, 2005-2006
  • Best Doctors in America®, 2007-2008
  • Best Doctors in America®, 2009-2010
  • Best Doctors in America®, 2011-2012
  • Best Doctors in America®, 2013-2014
  • Master Teacher Award, William Dock MD Award in Medicine, 2014

LECTURES:

  • Cardiac Devices and Infections. Presented at Cardiology Grand Rounds OSU, 2010
  • CDI Collaborative 2009 Update. Presented at CDC Prevention Epicenters Weekly Conference Call, 2010
  • Clostridium difficile Infections: Collaborative for the State of OH. Presented at Society for Healthcare Epidemiology of America (SHEA) Decennial Atlanta, Georgia, 2010
  • Clostridium difficile Infections: Collaborative for the State of Ohio. Presented at CDC Prevention Epicenter Face to Face Meeting, 2010
  • Microbiology of Device Infections: Prophylaxis, recognition and management of device infections. Presented at Managing Cardiac Implantable Lead Systems and Complication 2010: Guidance from The Experts Conference Ohio State University Medical Center, Columbus, OH, 2010
  • Regional CDI Workshop for the State of Pennsylvania. Presented at Health Care Improvement Foundation. Philadelphia, PA, 2010
  • Epidemiology Update. Presented at The Current Concepts in Clinical Nursing Practice Nursing Conference of The Ohio State University Medical Center, Columbus, Ohio, 2010
  • Large Scale Collaborative to Prevent Clostridium difficile: Successes and Challenges. Presented at Surveillance, Acquisition and Prevention of Clostridium difficile at SHEA Dallas, Texas, 2011
  • Large Scale Collaborative to Prevent C. difficile Infections: Successes and Challenges. Presented at Association for Professionals in Infection Control, Ohio Northwest Chapter Meeting, Toledo, OH, 2011
  • Clostridium difficile Epidemiology, Diagnosis and Management, Keynote Speaker at the OSU ID Update 2011.
  • Epidemiology, Pathophysiology, Diagnosis and Prevention of C. difficile Infections. Presented at the Combined Internal Medicine and General Surgery Grand Rounds. Co presenter, 2012
  • Clostridium difficile Infection: Pathophysiology and Diagnosis at the Making a Difference in Infectious Diseases (MAD-ID) 2012 Annual Pharmacy Meeting, Orlando, FL, 2012
  • Infection Prevention 2020: Beyond Hand Hygiene, Multi-disciplinary Approaches to Treatment of Critically Ill Hospitalized Patients (MATCH) Conference at COSI Col, OH, 2012
  • Agents of Bioterrorism. Presented at Grand Rounds Mount Carmel East Internal Medicine, Columbus, Ohio, 2013
  • Improving Hand Hygiene and Influenza Vaccination. Presented at Meet the Professor Lunch Session at the Annual SHEA Spring Meeting, Atlanta, Georgia, 2013
  • Addressing Environmental Issues at OSUWMC. Presented at the OSUWMC Executive Cabinet Meeting, 2013
  • Lunch with the Experts - Antimicrobial Stewardship. Presented at SHEA Spring Meeting, Denver, CO, 2014
  • Hot Topics in ID: Influenza Update. Presented at OSU Internal Medicine Grand Rounds, Columbus, Ohio, 2014
  • Clostridium difficile Update 2014. Presented at American Association of Physicians of Indian Origin Central Ohio (AAPIO CO), Columbus, OH, 2014
  • Advancing Public Reporting and Surveillance of Healthcare-associated Infections. IDSA Week, 2014

GRANTS:

  • CDC: Cooperative Agreement # 1 U01 CI0003280 Ohio State Health Network Infection Control Collaborative: Epicenters for Prevention of Healthcare Related Infections, Co-Investigator, 2006-2011
  • Clostridium difficile in Ohio: Standardizing Surveillance and Controlling Infections for 63 OH Hospitals, 2007-2011
  • Improving Medicine through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP), 2006-2008
  • APIC Research Foundation Comparing Administrative Coding Data to Epidemiologic, Co-Investigator, 2006-2007
  • Cepheid Clinical Evaluation of the Xpert™ MRSA Assay, Co-Investigator, 2006-20
  • Determining the distribution of Known Risk Factors in patients with Clostridium difficile, 2006-2007
  • Wyeth Pharmaceuticals Multidrug Resistant Acinetobacter baumannii Synergy Testing, 2006-2007
  • Mycoses Study Group and Merck and Co. A Randomized Double Blind, Placebo Controlled Trial of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in High-risk Adults in the Critical Care Setting, 2008-2010
  • Medline Industries, INC Quick Room Turnaround Time (QRTAT) Ultraviolet Light
  • Disinfection for Decreasing Healthcare Associated Infections, 2011
  • College of Medicine Medical Student Research Scholarship A Quality Initiative to Optimize Blood Glucose Control to Prevent Peripheral Vascular Bypass Graft Surgical Site Infections, 2010

PUBLICATONS:  [ Click here ]